Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Express Scripts (ESRX)

Express Scripts (ESRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,061,192
  • Shares Outstanding, K 563,860
  • Annual Sales, $ 100,065 M
  • Annual Income, $ 4,517 M
  • 60-Month Beta 0.88
  • Price/Sales 0.54
  • Price/Cash Flow N/A
  • Price/Book 2.53
  • Price/Earnings ttm 11.17
  • Earnings Per Share ttm 8.58
  • Most Recent Earnings 2.43 on 10/31/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 2.67
  • Number of Estimates 10
  • High Estimate 2.77
  • Low Estimate 2.58
  • Prior Year 2.16
  • Growth Rate Est. (year over year) +23.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.11 +0.24%
on 12/20/18
101.73 -9.24%
on 12/03/18
-2.96 (-3.11%)
since 11/20/18
3-Month
91.92 +0.45%
on 10/24/18
101.73 -9.24%
on 12/03/18
-2.71 (-2.85%)
since 09/20/18
52-Week
66.93 +37.95%
on 04/02/18
101.73 -9.24%
on 12/03/18
+18.34 (+24.79%)
since 12/20/17

Most Recent Stories

More News
MEDIA ALERT: Healthcare and Life Sciences Leaders to Reveal How to Digitally Transform in New Era of Consumerism at Healthcare Customer Engagement Summit

What: The Healthcare Customer Engagement Summit will bring together healthcare and life sciences industry experts from leading organizations like Sutter Health, Express Scripts, Health Alliance Plan, Optum,...

CELGZ : 0.46 (+2.22%)
ESRX : 92.33 (-3.62%)
PEGA : 74.00 (+0.09%)
Ignition Partners Congratulates Verity Solutions on Its Acquisition by Express Scripts, a Cigna Corporation Company

Ignitions Partners congratulates their portfolio company, Verity Solutions, on their acquisition by Express Scripts, a Cigna Corporation Company (NYSE:CI). As the result of the merger the companies will...

ESRX : 92.33 (-3.62%)
CI : 172.91 (+1.48%)
Cigna Corporation Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes

Cigna Corporation (NYSE:CI) ("Cigna") today announced the early results of its previously announced (1) offers to Eligible Holders (as defined below) to exchange (the "Exchange Offers") any and all of...

ESRX : 92.33 (-3.62%)
CI : 172.91 (+1.48%)
Express Scripts Has Returned 3.4% Since SmarTrend Recommendation (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 10 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Express Scripts Introduces 2020 Medicare Part D Plan Offerings

Express Scripts announced today its Express Scripts Medicare® prescription drug plan (PDP) offerings for 2020, with three high-value options for coverage and savings - Saver, Value and Choice - including...

ESRX : 92.33 (-3.62%)
Downtrend Call Working As Express Scripts Stock Falls 3.4% (ESRX)

SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on December 10th, 2018 at $95.57. In approximately 10 months, Express Scripts has returned 3.39% as of today's recent price of $92.33....

ESRX : 92.33 (-3.62%)
Cigna Corporation Announces Exchange Offers and Consent Solicitations for Senior Notes of Cigna Holding Company, Express Scripts Holding Company and Medco Health Solutions, Inc.

Cigna Corporation (NYSE: CI) ("Cigna") today announced the commencement of private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all of certain outstanding...

ESRX : 92.33 (-3.62%)
CI : 172.91 (+1.48%)
Chuck Conroy Appointed CEO of ARTMS

ARTMS Products Inc., the global leader in the innovation and commercialization of novel technologies that enable cyclotron production of the world's most needed medical radioisotopes, is pleased to announce...

LLY : 107.40 (-2.22%)
ESRX : 92.33 (-3.62%)
Cigna Health Services Business Pioneers an Innovative Solution to Affordably Bring Life-Changing Therapies to Patients

Breakthrough, potentially life-changing medicines offer great promise for patients and their families. However, the high prices of the medicines - millions of dollars in some cases - threaten coverage...

ESRX : 92.33 (-3.62%)
CI : 172.91 (+1.48%)
Cigna, Express Scripts Implement Emergency Procedures for People Affected by Hurricane Dorian

Global health service company Cigna (NYSE: CI) and its Express Scripts unit are helping residents of Florida affected by Hurricane Dorian by easing some health benefits plan and prescription requirements,...

ESRX : 92.33 (-3.62%)
CI : 172.91 (+1.48%)
Trade ESRX with:

Business Summary

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy...

See More

Key Turning Points

2nd Resistance Point 97.20
1st Resistance Point 94.76
Last Price 92.33
1st Support Level 91.00
2nd Support Level 89.68

See More

52-Week High 101.73
Last Price 92.33
Fibonacci 61.8% 88.44
Fibonacci 50% 84.33
Fibonacci 38.2% 80.22
52-Week Low 66.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar